Meeting
2016 ASCO Annual Meeting
Quantification of circulating clonal plasma cells (cPCs) via multiparametric flow cytometry (MFC) to identify patients with smoldering multiple myeloma (SMM) at high risk of progression.
Authors
Wilson I. Gonsalves
Division of Hematology, Mayo Clinic, Rochester, MN
Wilson I. Gonsalves , S. Vincent Rajkumar , Michael Timm , William Morice , Angela Dispenzieri , Martha Lacy , Francis Buadi , David Dingli , Ronald S. Go , Nelson Leung , Prashant Kapoor , Suzanne R. Hayman , John Anthony Lust , Stephen Russell , Steven R. Zeldenrust , Taxiarchis Kourelis , Yi Lisa Hwa , Robert A. Kyle , Morie A. Gertz , Shaji Kumar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies—Plasma Cell Dyscrasia
Sub Track
Multiple Myeloma
Citation
J Clin Oncol 34, 2016 (suppl; abstr 8015)
DOI
10.1200/JCO.2016.34.15_suppl.8015
Abstract #
8015
Poster Bd #
280
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
African American patients with smoldering multiple myeloma may have a lower risk of progression compared to White patients.
First Author: Theresia Akhlaghi
Poster
2017 ASCO Annual Meeting
The impact of body mass index on the risk of early progression of smoldering multiple myeloma to symptomatic myeloma.
First Author: Wilson I. Gonsalves
Poster
2017 ASCO Annual Meeting
Risk stratification by detection of clonal circulating plasma cells (CPCs) by multi-parametric flow cytometry (MFC) in light chain amyloidosis (AL).
First Author: Surbhi Sidana
Poster
2015 ASCO Annual Meeting
The prognostic significance of CD45 expression by clonal bone marrow plasma cells in multiple myeloma.
First Author: Wilson I. Gonsalves